Clinical Trial Update: Sandostatine® LP and Hyperinsulinism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Sandostatine LP for congenital hyperinsulinism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hyperinsulinism

Drugs mentioned

• Sandostatine LP (octreotide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Congenital Hyperinsulinism | Phase 2 | Status: COMPLETED